Profile
Shmulik Hess was the founder of Active P Ltd., where the company was founded in 2008 and the title held was Chief Executive Officer in 2011.
Dr. Hess is currently the Chief Operating & Commercial Officer at MediWound Ltd. since 2023.
Former positions include Chief Executive Officer at Enlivex Therapeutics Ltd., Chief Executive Officer at Valin Technologies Ltd. from 2010 to 2018, Chief Executive Officer at Tabby Therapeutics Ltd., and Global Operations at SciGen Pte Ltd. from 2008 to 2010.
Education includes a doctorate from The Hebrew University of Jerusalem.
Shmulik Hess active positions
| Companies | Position | Start |
|---|---|---|
| MEDIWOUND LTD. | Chief Operating Officer | 01/12/2023 |
Former positions of Shmulik Hess
| Companies | Position | End |
|---|---|---|
Valin Technologies Ltd.
Valin Technologies Ltd. BiotechnologyHealth Technology Engages in research and development of therapeutics & of biosimilars | Chief Executive Officer | 01/11/2018 |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary novel oral available peptide drugs to treat diabetes | Chief Executive Officer | 01/09/2011 |
| SCIGEN LIMITED | Chief Operating Officer | 01/03/2010 |
| ENLIVEX | Chief Executive Officer | - |
Tabby Therapeutics Ltd.
Tabby Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutic drugs | Chief Executive Officer | - |
Training of Shmulik Hess
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
SciGen Pte Ltd.
SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures, markets & develops biopharmaceutical products | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MediWound Ltd.
MediWound Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes bio-therapeutic solutions for tissue repair and regeneration | Health Technology |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary novel oral available peptide drugs to treat diabetes | Health Technology |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Valin Technologies Ltd.
Valin Technologies Ltd. BiotechnologyHealth Technology Engages in research and development of therapeutics & of biosimilars | Health Technology |
Tabby Therapeutics Ltd.
Tabby Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutic drugs | Health Technology |
- Stock Market
- Insiders
- Shmulik Hess
















